Showing results (441-450 of 3,348) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|December 10, 1991
Challenging official health cost estimates: an alternative view that incorporates the behavioural and economic effects of policy changesA Robbins, G RobbinsPharmacoeconomics|December 10, 1991
Australian guidelines for cost-effectiveness studies of pharmaceuticals: the thin end of the boomerang?M DrummondPharmacoeconomics|February 7, 1993
The cost of asthma: can it be reduced?C M Mellis, J K Peat, A J WoolcockPharmacoeconomics|February 7, 1993
A cost-effectiveness analysis of epoetin usage for patients with AIDSS B Cantor, R W Carson, S J SpannPharmacoeconomics|July 7, 1992
The UK indicative prescribing scheme: background and operationJ Bligh, T WalleyPharmacoeconomics|June 7, 1993
Tamoxifen: a review of pharmacoeconomic and quality-of-life considerations for its use as adjuvant therapy in women with breast cancerH M Bryson, G L PloskerPharmacoeconomics|July 7, 1993
Economic impact of cost-containment strategies in third party programmes in the US (part I)C E Reeder, E W Lingle, R M Schulz, et al.Pharmacoeconomics|June 7, 1992
Assessing the responsiveness of a quality-of-life instrument and the measurement of symptom severity in essential hypertensionM C Reilly, A S ZbrozekPharmacoeconomics|December 9, 1992
Cost-effectiveness of antihypertensive treatment: metoprolol versus thiazide diureticsM Johannesson, J Wikstrand, B Jönsson, et al.Pharmacoeconomics|December 9, 1992
Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of lifeR Whittington, L B Barradell, P BenfieldPageof 335